Vasopressin Receptors in Human Adrenal Medulla and Pheochromocytoma1
Eric Grazzini,
Christophe Breton,
Sylvain Derick,
Miriam Andres,
Danièle Raufaste,
Frédérique Rickwaert,
Gilles Boccara,
Pascal Colson,
Nathalie C. Guérineau,
Claudine Serradeil-Le Gal and
Gilles Guillon
INSERM U-469, CCIPE (E.G., C.B., S.D., N.C.G., G.G.), 34094
Montpellier Cedex 05; SANOFI Recherche Toulouse (D.R., C.S.-L.G.),
31036 Toulouse; and Département dAnesthésie,
Réanimation B, Hôpital Arnaud de Villeneuve (F.R., G.B.,
P.C.), 34295 Montpellier, France
Address all correspondence and request for reprints to: Gilles Guillon, INSERM U-469, Centre CNRS-INSERM de Pharmacologie Endocrinologie, 141 rue de la Cardonille, 34094 Montpellier Cedex 05, France. E-mail: guillon{at}u469.montp.inserm.fr
The nature of vasopressin (VP) receptors present in normal andtumoral
human adrenal was investigated using various experimentalapproaches.
Specific VP-binding sites were detected by autoradiographyusing
[3H]arginine VP as a radioligand in adrenal cortex and
medulla.The V1a receptor subtype was expressed in the two parts of the
gland,as shown by pharmacological studies and RT-PCR experiments.By
contrast, the V1b receptor subtype was only expressed inmedullary
chromaffin cells. This was confirmed by the characterizationof V1b
transcripts detected in adrenal medulla tissues. In
pheochromocytoma,we also detected functional V1b receptors. These
receptors triggeredintracellular calcium mobilization from
intracellular poolsand were involved in catecholamine secretion.
Binding experimentsperformed on pheochromocytoma plasma membrane
preparations alsorevealed V1a vasopressin-binding sites, whose roles
and cellularlocalization have not yet been determined. RT-PCR
experimentsconfirmed these data; 100% and 80% of the five tumors
testedexhibited V1a and V1b transcripts, respectively. Perifusion
experimentsalso demonstrated that some pheochromocytomas may secrete
largeamounts of VP. Our findings imply that VP locally secreted by
humanadrenal medulla may regulate adrenal function by acting on V1aor
V1b receptors. More interestingly, we demonstrate that one
pheochromocytomaoversecretes VP. In this particular case, this may
contributeto the increase in blood pressure observed.
This article has been cited by other articles:
U. Saleem, M. Khaleghi, N. G. Morgenthaler, A. Bergmann, J. Struck, T. H. Mosley Jr., and I. J. Kullo Plasma Carboxy-Terminal Provasopressin (Copeptin): A Novel Marker of Insulin Resistance and Metabolic Syndrome
J. Clin. Endocrinol. Metab.,
July 1, 2009;
94(7):
2558 - 2564.
[Abstract][Full Text][PDF]
E Louiset, V Contesse, L Groussin, D Cartier, C Duparc, V Perraudin, J Bertherat, and H Lefebvre Expression of vasopressin receptors in ACTH-independent macronodular bilateral adrenal hyperplasia causing Cushing's syndrome: molecular, immunohistochemical and pharmacological correlates
J. Endocrinol.,
January 1, 2008;
196(1):
1 - 9.
[Abstract][Full Text][PDF]
C. S.-L. Gal, D. Raufaste, S. Derick, J. Blankenstein, J. Allen, B. Pouzet, M. Pascal, J. Wagnon, and M. A. Ventura Biological characterization of rodent and human vasopressin V1b receptors using SSR-149415, a nonpeptide V1b receptor ligand
Am J Physiol Regulatory Integrative Comp Physiol,
August 1, 2007;
293(2):
R938 - R949.
[Abstract][Full Text][PDF]
M. Otis, S. Campbell, M. D Payet, and N. Gallo-Payet Expression of extracellular matrix proteins and integrins in rat adrenal gland: importance for ACTH-associated functions
J. Endocrinol.,
June 1, 2007;
193(3):
331 - 347.
[Abstract][Full Text][PDF]
J. Bertherat, V. Contesse, E. Louiset, G. Barrande, C. Duparc, L. Groussin, P. Emy, X. Bertagna, J.-M. Kuhn, H. Vaudry, et al. In Vivo and in Vitro Screening for Illegitimate Receptors in Adrenocorticotropin-Independent Macronodular Adrenal Hyperplasia Causing Cushing's Syndrome: Identification of Two Cases of Gonadotropin/Gastric Inhibitory Polypeptide-Dependent Hypercortisolism
J. Clin. Endocrinol. Metab.,
March 1, 2005;
90(3):
1302 - 1310.
[Abstract][Full Text][PDF]